Senior Trade Operations Specialist at Gilead Sciences

Uxbridge, England, United Kingdom

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Expertise in managing commercial supply chains within GPS region through collaboration with commercial leads and distributors
Ability to minimize forecast volatility, support new product introduction, and manage cross-functional order books with stakeholders (Customer Service, Supply Planning, Quality, Regulatory, Artwork & Label Operations)
Proficiency in supporting Voluntary Licenses (VL) Dashboard and Trade Operations reporting
Skills in data collection, preparation, QC checks, and dashboard updates using Excel and Tableau
Experience in quality evaluation of Purchase Orders in compliance with Distribution Agreements

Responsibilities

Manage the commercial supply chain within the GPS region through close collaboration between commercial leads and distributors to minimize forecast volatility, support new product introduction, and ensure uninterrupted supply to markets
Handle cross-functional order book management with Gilead stakeholders including Customer Service, Supply Planning, Quality, Regulatory, Artwork & Label Operations
Support the Voluntary Licenses (VL) Dashboard and related Trade Operations reporting, ensuring accuracy, timeliness, and reliability of market data for business decisions across therapeutic areas
Perform data collection, preparation, QC checks, and dashboard updates using Excel and Tableau
Conduct quality evaluation of Purchase Orders in compliance with Distribution Agreements

Skills

Trade Operations

Supply Chain Management

Global Trade Compliance

Regulatory Affairs

Patient Access Programs

Public Health Partnerships

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free